Pursuant to Regulation 30 & 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you hereby informed that the Board of Directors in ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Modern Diagnostic & Research Centre Ltd, a diagnostic services company listed on BSE SME platform, has released its audited financial results for FY 2025-26 ending March 31, 2026. Total income for the year stood at Rs 8,413.71 Lacs compared to Rs 7,880.46 Lacs in the previous year, representing approximately 6.6% revenue growth. However, profit after tax declined significantly to Rs 525.33 Lacs from Rs 900.79 Lacs in the prior year - a drop of about 42%. EPS also declined from Rs 8.19 to Rs 3.48 per share. The company completed its IPO in January 2026, raising Rs 36.89 Crores, and utilized Rs 1,571.62 Lacs of IPO proceeds by year-end, primarily for capital expenditure and working capital. The statutory auditor has issued an unmodified opinion on the financial statements.
The significant decline in profitability despite modest revenue growth raises concerns about cost management. Shareholders should note the sharp drop in EPS and PAT, though the company maintains positive operating cash flows and completed its IPO successfully.